Furthermore, we hypothesized that these effects could be greatly influenced by inflammatory activation of CF, for which we stimulated CF TLR4 receptor, a well-studied receptor involved in pro-inflammatory fibroblast functions, with lipopolysaccharide (LPS), a TLR4 specific agonist, to promote CF inflammatory environment. The gene discussed is CFTR; the disease is cystic fibrosis.